Patra NeurosurgicalPatient education

Procedure

Deep brain stimulation (DBS) for epilepsy

An implanted device that stimulates the anterior nucleus of the thalamus, an area deep in the brain, on both sides. Its goal is fewer seizures in adults with focal epilepsy that medicines have not controlled.

How this page was written
Compiled from the sources cited on the page, with AI drafting assistance
Clinical review
Not individually reviewed by a clinician. How pages are written
Last updated
November 17, 2026

General information, not medical advice. In an emergency call 911. Full disclaimer

What it does

Thin wires are placed on both sides of the brain in the anterior nucleus of the thalamus. The thalamus is a relay area deep in the brain. [1] The wires connect to a pulse generator, a device similar to a heart pacemaker, which sends stimulation to the area. [2]

Unlike responsive neurostimulation, which stimulates only when it detects a seizure pattern, DBS does not wait for a detection. [3]

DBS is also used for movement problems, such as Parkinson disease, essential tremor, and dystonia. For those conditions it is aimed at brain areas that control movement, and the expected results are different. [4] See DBS for movement disorders.

When it is considered

The FDA approved DBS for epilepsy (Medtronic DBS Therapy for Epilepsy) in 2018 for adults 18 and older who have:

It was tested in people with an average of 6 or more seizures a month. It has not been studied in people with fewer seizures. It is approved as an add-on to medicine. [1]

Unlike RNS, the approved use of DBS does not require the team to find exactly where seizures start. [1] [3] You will still need an epilepsy surgery evaluation to see whether surgery that removes the seizure area might be a better choice.

Use in children, or for types of epilepsy outside the approved indication, is off label. [1]

What matters most in the decision

DBS aims to reduce seizures. A long seizure-free stretch is possible but uncommon. In the main trial, benefit grew over several years. [5] People in the trial who had stimulation reported depression or memory problems more often than those who did not. [6]

Preparation and what happens

The surgeon places the wires on both sides of the brain and connects them to the pulse generator. [1] [2]

Expected benefits

The SANTE trial. This trial included 110 adults with focal seizures. Before surgery they had a median of about 20 seizures a month. For 3 months, half had stimulation and half did not, without knowing which. At the end of those 3 months, seizures had dropped by a median of 40% in the stimulation group and 15% in the other group. [6]

Fewer seizures over time. After the blinded phase, everyone had stimulation.

Seizure freedom. During the 5 years, 16 out of 100 people had at least 6 months in a row without seizures. [5]

Quality of life and seizure severity improved by 1 year and stayed better at 5 years. [5]

The long-term results come from an open follow-up without a comparison group, so they are less certain than the 3-month trial results. [5]

Fewer seizure-related injuries. The published trial summaries do not report on injuries from seizures. [6] [5]

Risks and complications

Surgery. In the trial, no one had bleeding in the brain that caused symptoms, and no one had a brain infection. Five people died during the study. None of the deaths were caused by the implant or the stimulation. [6]

Device problems. By 5 years, 34 out of 100 people had a serious problem related to the device. [5]

Seizures with stimulation. Two people had short-lived seizures linked to stimulation. [6]

Mood and memory. Formal tests of thinking and mood showed no difference between groups. But people who had stimulation were more likely to report depression or memory problems as side effects. [6] Tell your team if you or your family notice changes in mood or memory.

Alternatives

Recovery and follow-up

In the long-term study, doctors adjusted the stimulation settings over time, so expect follow-up visits for programming. [5] Keep taking your medicine as prescribed. Any plan to change your medicine should come from your treating team. Recovery varies. Follow the discharge instructions from your own team.

Questions to ask

  1. Why do you suggest DBS for me instead of RNS or surgery?
  2. What drop in seizures is realistic for me, and how long might it take?
  3. How will you watch for changes in mood and memory?
  4. How often will I need programming visits?
  5. How long does the battery last, and how is it replaced?

Sources

  1. Premarket Approval Supplement P960009/S219: Medtronic DBS Therapy for Epilepsy. US Food and Drug Administration. Published April 27, 2018. Open source
  2. Epilepsy and Seizures. National Institute of Neurological Disorders and Stroke. Published March 13, 2026. Open source
  3. Nair DR, Laxer KD, Weber PB, et al. Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy. Neurology. 2020;95(9):e1244-e1256. Published September 1, 2020. Open source
  4. Deep brain stimulation. MedlinePlus Medical Encyclopedia. US National Library of Medicine. Published October 27, 2025. Open source
  5. Salanova V, Witt T, Worth R, et al. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology. 2015;84(10):1017-1025. Published March 1, 2015. Open source
  6. Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899-908. Published May 1, 2010. Open source